ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

May 27, 2011

Appropriations: NIH Professional Needs Budget Gains Attention

March 14, 1997

In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building

October 22, 1999

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

In Brief: Markup Of Cancer Act Renewal Bill Oct. 31; Garfinkel New ACS VP For Epidemiology

October 19, 1979